Research Topics
Genomes and GenesSpecies | D Scott SchmidSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Varicella-zoster virus vaccine: molecular geneticsD Scott Schmid
Herpesvirus Team and National VZV Laboratory, MMRHLB, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Curr Top Microbiol Immunol 342:323-40. 2010....
Impact of varicella vaccine on varicella-zoster virus dynamicsD Scott Schmid
Herpesvirus Team and National VZV Laboratory, Measles, Mumps, Rubella, and Herpesvirus Laboratory Branch, Centers for Disease Control and Prevention, National Center for Immunizations and Respiratory Diseases, Division of Viral Diseases, Atlanta, Georgia 30333, USA
Clin Microbiol Rev 23:202-17. 2010..Since disease symptoms often resolve in outbreak settings before suitable test specimens can be obtained, the need to develop new diagnostic approaches that rely on alternative patient samples is also discussed...- Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicityAdam MacNeil
National Center for Zoonotic, Vector Borne, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 48:e6-8. 2009..Genotyping results confirmed the VZV strain European E2, a genotype not previously reported in Africa. VZV with palm and sole involvement should be considered when differentiating a monkeypox diagnosis... - Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004Adriana S Lopez
National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
J Infect Dis 197:646-53. 2008.... - Distribution of varicella-zoster virus (VZV) wild-type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypesVladimir N Loparev
National VZV Laboratory, Centers for Disease Control and Prevention, Coordinating Center for Infectious Diseases, National Center for Preparedness, Detection, and Control of Infectious Diseases, Atlanta, GA, USA
Virology 383:216-25. 2009..No M3 or J strains were observed... - Evaluation of laboratory methods for diagnosis of varicellaJessica Leung
Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA 30333, USA
Clin Infect Dis 51:23-32. 2010..We conducted a comprehensive evaluation of laboratory tests and specimen types to assess diagnostic performance and determine what role testing can play after skin lesions have resolved... 
DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccineVladimir N Loparev
National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Infect Dis 195:502-10. 2007..5%-97.4% of isolates (mean frequency, 67.7%). No 2 clinical isolates had identical SNP profiles; as such, vaccine latency usually involves >1 strain...- An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006Philip L Gould
Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 28:678-81. 2009..In October 2006, the Arkansas Department of Health was notified of a varicella outbreak among students where some received a second dose during an outbreak-related vaccination campaign in February 2006... - Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New ZealandVladimir N Loparev
Centers for Disease Control and Prevention, National Center for Preparedness, Detection, and Control of Infectious Diseases, Atlanta, Georgia 30333, USA
J Virol 81:12758-65. 2007..Two-amplicon typing was in complete accord with genotypes derived using SNP in multiple ORFs (ORFs 1, 21, 22, 38, 50, 54, and 62). Two additional minor genotypes, M3 and M4, could also be resolved using two-amplicon typing... - Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the CongoAdam MacNeil
Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Am J Trop Med Hyg 80:503-7. 2009..Improvements in rash illness surveillance and infection control, through training of health workers and timely acquisition of diagnostic specimens, are being undertaken... - A 2009 varicella outbreak in a Connecticut residential facility for adults with intellectual disabilityJessica Leung
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 202:1486-91. 2010..Evidence of immunity should be verified for all adults and healthcare staff in similar residential settings... - Review of cytomegalovirus seroprevalence and demographic characteristics associated with infectionMichael J Cannon
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention CDC, Atlanta, GA 30329, USA
Rev Med Virol 20:202-13. 2010..Future vaccine or educational campaigns to prevent primary infection in pregnant women may need to be tailored to suit the needs of different populations... - Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zosterMark L Quinlivan
Division of Viral Diseases, Measles, Mumps, Rubella, and Herpesvirus Laboratory Branch, Centers for Disease Control and Prevention, Office of Infectious Diseases, National Center for Immunizations and Respiratory Diseases, Atlanta, Georgia, USA
J Clin Microbiol 50:1533-8. 2012..Characterization of all four vOka markers in ORF62 and of the clade 2 subtype marker in ORF38 is now necessary to confirm vOka adverse events... - National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG aviditySheila C Dollard
Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA
Clin Vaccine Immunol 18:1895-9. 2011..Both IgM and IgG avidity measurements provide useful clinical information for evaluating primary CMV infection, although commercial tests for CMV IgG avidity are not yet widely available in the United States... - Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infectionMichael J Cannon
National Center on Birth Defects and Developmental Disabilities, Atlanta, GA, USA
Rev Med Virol 21:240-55. 2011..Higher CMV viral load at birth also consistently correlated with the presence of symptoms of congenital CMV at birth. Published 2011. This article is a US Government work and is in the public domain in the USA... - Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and SpainVladimir Loparev
Biotechnology Core Facility, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Clin Microbiol 45:559-63. 2007..The two genotyping methods, using entirely different genomic targets, produced identical clusters for the strains examined, suggesting robust phylogenetic linkages among VZV strains circulating in Europe... - Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmissionJennifer D Stowell
Division of Viral Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 205:211-4. 2012..CMV was cultured from 83 of 90 wet and 5 of 40 dry surfaces. CMV was more likely to be isolated from wet, highly absorbent surfaces at earlier time points... - Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005Sandra S Chaves
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 197:S170-7. 2008..Ongoing safety surveillance and further studies may shed light on some of the hypothesized associations... - Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement--Maine, 2006Amy A Parker
Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention CDC, Atlanta, Georgia, USA
J Infect Dis 197:S101-7. 2008..These findings support ACIP's June 2007 recommendation for a routine 2-dose varicella vaccination program... - One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?Adriana S Lopez
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pediatrics 117:e1070-7. 2006.... - Molecular studies of the Oka varicella vaccineMark Quinlivan
Herpesvirus Team and National VZV Laboratory, MMRHLB, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Expert Rev Vaccines 10:1321-36. 2011..We present here a review of what has been learned thus far about the molecular and phenotypic characteristics of the Oka vaccine... - Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counselingSami L Gottlieb
Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA
J Infect Dis 190:1059-67. 2004..controls). The possible benefit of RRC in preventing acquisition of HSV-2 infection offers encouragement that interventions more specifically tailored to genital herpes may be useful and should be an important focus of future studies... - Challenges in confirming a varicella outbreak in the two-dose vaccine eraAbdirahman Mahamud
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Vaccine 30:6935-9. 2012..A second dose of varicella vaccine was recommended for U.S. children in 2006. We investigated a suspected varicella outbreak in School District X, Texas to determine 2-dose varicella vaccine effectiveness (VE)... - Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002Gustavo H Dayan
Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, MS E 61, 1600 Clifton Rd, Atlanta, GA 30333, USA
J Clin Microbiol 42:5698-704. 2004..In Argentina, seroprevalence in women more than 15 years old was high regardless of the area of residence. Negative or uncertain varicella history was not a good predictor of immunity. VZV genotype was stable in all areas of the country... - Varicella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999-2004Meredith A Reynolds
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Public Health Rep 125:860-9. 2010.... - Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)Rafael Harpaz
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, USA
MMWR Recomm Rep 57:1-30; quiz CE2-4. 2008..Before administration of zoster vaccine, patients do not need to be asked about their history of varicella (chickenpox) or to have serologic testing conducted to determine varicella immunity... - High rate of varicella complications among Mexican-born adults in AlabamaM Carolina Danovaro-Holliday
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
Clin Infect Dis 39:1633-9. 2004.... - Regulation of the expression of the varicella-zoster virus open reading frame 66 geneJennifer M Folster
Division of Viral Diseases, Measles, Mumps, Rubella, and Herpesvirus Laboratory Branch, Centers for Disease Control and Prevention, Office of Infectious Diseases, National Center for Immunizations and Respiratory Diseases, Atlanta, GA 30333, USA
Virus Res 155:334-42. 2011..We also examined the effect of Sp1 and TBP mutations on IE62, Sp1, and TBP binding. These studies reveal that host cell-derived and viral factors contribute to and cooperate in the expression of this important viral kinase gene... - Neonatal vaccine-strain varicella-zoster virus infection 22 days after maternal postpartum vaccinationMargaret Kluthe
Midtown Community Health Center, Children s Clinic, Suite A, Ogden, UT 84405, USA
Pediatr Infect Dis J 31:977-9. 2012..The mother had no postvaccination rash nor did other contacts have rash or recent vaccination. The potential means of transmission to the infant are explored... - Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMVTerri B Hyde
National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention CDC, Atlanta, GA 30329, USA
Rev Med Virol 20:311-26. 2010..The relatively low rate of CMV seroconversion in most populations is encouraging for behavioural interventions and for vaccine strategies attempting to prevent infection during pregnancy... - Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotypingVladimir N Loparev
Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Virol 78:8349-58. 2004..These data highlight the direction for future VZV genotyping efforts. This approach provides the first simple genotyping method for VZV strains in clinical samples... - Human monkeypox infection: a family cluster in the midwestern United StatesJames J Sejvar
Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA
J Infect Dis 190:1833-40. 2004..We describe a cluster of monkeypox in a family with a spectrum of clinical illness, including encephalitis, and outline the laboratory confirmation of monkeypox... - Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected womenCynthia T Stover
Emory University, Atlanta, Georgia, USA
J Infect Dis 187:1388-96. 2003..Disadvantaged women and women who engage in high-risk behaviors are more likely to be coinfected with HIV and other viruses and, thus, may be at high risk of serious disease sequelae...